Literature DB >> 11895215

Low individualized growth hormone (GH) dose increased renal and cardiac growth in young adults with childhood onset GH deficiency.

K Link1, B Bülow, K Westman, E C Salmonsson, J Eskilsson, E M Erfurth.   

Abstract

OBJECTIVE: In childhood onset GH deficiency (GHD) a reduction in left ventricular mass (LV-mass) and impairment of systolic function as well an impairment in glomerular filtration rate (GFR) has been shown. The aim of the present study was to assess if a low GH dose resulted in an improvement in morphological and functional parameters of these organs. DESIGN AND PATIENTS: Eleven patients with childhood onset GHD were investigated before and after 10 months of GH treatment at a dose of 1.5 IU/day (range 1-2), corresponding to 0.02 IU/kg/day or 7 microg/ kg/day. The GH dose resulted in a serum IGF-I level in the normal range in all but one patient. MEASUREMENTS: Doppler echocardiography of the heart and ultrasound examination of the kidneys was performed. Glomerular filtration rate (GFR) was estimated with iohexol clearance and urinary proteinuria was measured with 24-h urinary samples collected for analyses of albumin, alpha-1-microglobulin, IgG and albumin/creatinine clearance ratio. Body composition was measured by bioelectric impedance analysis.
RESULTS: L V-mass index increased significantly after GH treatment (P = 0.04), and there was a clear trend for a positive correlation between the increase in serum IGF-I and the increase in LV-mass index, although it did not reach significance (r= 0.57, P = 0.07). GH treatment did not increase cardiac fractional shortening. Kidney length increased significantly (P = 0.02) with an average increase of 1 cm (range - 0.5-1.5 cm). No significant changes in median GFR or serum creatinine were recorded. Three patients with subnormal GFR before GH treatment normalized after 10 months of treatment. Urine analysis showed no abnormalities before or after GH treatment. A significant decrease in percentage fat mass was recorded (P = 0.03).
CONCLUSION: A low individualized GH dose to adults with childhood onset GHD resulted in an increase in LV-mass index and kidney length. Re-establishing GH treatment with a low dose in this patient group can lead to a further somatic maturation of these organs, probably not accomplished previously.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11895215     DOI: 10.1046/j.1365-2265.2001.01413.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  6 in total

1.  Cardiac function in growth hormone deficient patients before and after 1 year with replacement therapy: a magnetic resonance imaging study.

Authors:  Mikkel Andreassen; Jens Faber; Andreas Kjaer; Claus Leth Petersen; Lars Østergaard Kristensen
Journal:  Pituitary       Date:  2011-03       Impact factor: 4.107

2.  Structural, functional and autonomic changes in the cardiovascular system in growth hormone deficient patients.

Authors:  Doğan Erdoğan; Tufan Tükek; Ferihan Aral; Hüseyin Oflaz; Mehmet Ozaydin; Orhan Kocaman; Vakur Akkaya; Taner Gören; Senay Molvalilar
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-01       Impact factor: 1.468

3.  Three weekly injections (TWI) of low-dose growth hormone (GH) restore low normal circulating IGF-I concentrations and reverse cardiac abnormalities associated with adult onset GH deficiency (GHD).

Authors:  A I Pincelli; R Bragato; M Scacchi; G Branzi; G Osculati; R Viarengo; G Leonetti; F Cavagnini
Journal:  J Endocrinol Invest       Date:  2003-05       Impact factor: 4.256

4.  The potential effects of anabolic-androgenic steroids and growth hormone as commonly used sport supplements on the kidney: a systematic review.

Authors:  Dorna Davani-Davari; Iman Karimzadeh; Hossein Khalili
Journal:  BMC Nephrol       Date:  2019-05-31       Impact factor: 2.388

5.  Effects of human recombinant growth hormone on exercise capacity, cardiac structure, and cardiac function in patients with adult-onset growth hormone deficiency.

Authors:  S Gonzalez; J D Windram; T Sathyapalan; Z Javed; A L Clark; S L Atkin
Journal:  J Int Med Res       Date:  2017-08-31       Impact factor: 1.671

6.  Renal effects of growth hormone in health and in kidney disease.

Authors:  Dieter Haffner; Andrea Grund; Maren Leifheit-Nestler
Journal:  Pediatr Nephrol       Date:  2021-06-18       Impact factor: 3.714

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.